Evidence map›Paper›PMID 21590284›Full record

ArticlePsychopharmacology2011

Methylphenidate increases cigarette smoking in participants with ADHD.

Andrea R Vansickel, William W Stoops, Paul E A Glaser, Megan M Poole, Craig R Rush

Open access · greenAbstract readControlled Clinical Trial
In one paragraph

Article in Psychopharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Increasing the Value of an Alternative Monetary Reinforcer Reduces Cigarette Choice in Adolescents.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Article
  13. Nicotine Addiction and Psychiatric Disorders.International review of neurobiology · 2015
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Andrea R VansickelDepartment of Behavioral Science, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.
William W Stoops
Paul E A Glaser
Megan M Poole
Craig R Rush
University of Kentucky · USLexington VA Health Care System · US

Funding

TRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7M
RESEARCH TRAINING IN DRUG ABUSE BEHAVIORT32DA007304 · NIDA · UNIVERSITY OF KENTUCKY · PI RUSH, CRAIG R · 1998 to 2012
$3.1M
Moleclar Pathogenesis of Retinitis Pigmentosa Type 3R01EY012665 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI FERREIRA, PAULO A. · 2001 to 2004
$1.2M
ASSESSING ABUSE POTENTIAL IN HUMAN--CNS STIMULANTSR01DA012665 · NIDA · UNIVERSITY OF KENTUCKY · PI RUSH, CRAIG R · 2001 to 2004
$1.2M
Internet Based Voucher Reinforcement for Smoking CessationR21CA124881 · NCI · UNIVERSITY OF KENTUCKY · PI STOOPS, WILLIAM WALTON · 2007 to 2008
$327k
NCI NIH HHS R21 CA 124881NCI NIH HHS R21 CA124881NEI NIH HHS R01 EY012665NIDA NIH HHS R01 DA 012665NIDA NIH HHS R01 DA012665NIDA NIH HHS T32 DA007027NIDA NIH HHS T32 DA 007027-34NIDA NIH HHS T32 DA007304
6 · The paper itself

Abstract

rationaleMethylphenidate (Ritalin®) is commonly prescribed for behavioral problems associated with attention deficit/hyperactivity disorder (ADHD). The results of previous studies suggest that methylphenidate increases cigarette smoking in participants without psychiatric diagnoses. Whether methylphenidate increases cigarette smoking in participants diagnosed with ADHD is unknown.

objectiveIn this within-subjects, repeated measures experiment, the acute effects of a range of doses of methylphenidate (10, 20, and 40 mg) and placebo were assessed in nine cigarette smokers who were not attempting to quit and met diagnostic criteria for ADHD but no other Axis I psychiatric disorders other than nicotine dependence.

methodsEach dose of methylphenidate was tested once while placebo was tested twice. One hour after ingesting drug, participants were allowed to smoke ad libitum for 4 h. Measures of smoking included total cigarettes smoked, total puffs, and carbon monoxide levels. Snacks and decaffeinated drinks were available ad libitum; caloric intake during the 4-h smoking session was calculated.

resultsMethylphenidate increased the total number of cigarettes smoked, total number of puffs, and carbon monoxide levels. Methylphenidate decreased the number of food items consumed and caloric intake.

conclusionsThe results of this experiment suggest that acutely administered methylphenidate increases cigarette smoking in participants with ADHD, which is concordant with findings from previous studies that tested healthy young adults. These data indicate that clinicians may need to consider non-stimulant options or counsel their patients before starting methylphenidate when managing ADHD-diagnosed individuals who smoke.

Indexed as

AdultAttention Deficit Disorder with HyperactivityCarbon MonoxideCentral Nervous System StimulantsDose-Response Relationship, DrugDouble-Blind MethodEatingEnergy IntakeFemaleHumansMaleMethylphenidateSmokingYoung AdultCarbon MonoxideCentral Nervous System StimulantsMethylphenidate

Identifiers

PMID21590284
PMCPMC3189423
OpenAlexW2142776057

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.